DABIGATRAN

✅ DABIGATRAN (CAS 211915-06-9) – PRODUCT DESCRIPTION

Dabigatran (CAS 211915-06-9) is an oral anticoagulant used primarily for the prevention and treatment of blood clots. It works as a direct thrombin inhibitor, blocking the activity of thrombin and thereby reducing the formation of clots. Dabigatran is used in the treatment of atrial fibrillation to reduce the risk of stroke, and also for deep vein thrombosis (DVT) and pulmonary embolism (PE) prevention. Unlike traditional warfarin, Dabigatran has a more predictable pharmacological profile, and no routine monitoring is required. This white to off-white crystalline powder is available in pharmaceutical grades (IP/BP/USP), ensuring high purity and quality for oral formulations. We supply Dabigatran to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (treatment of bacterial infections, including UTIs, respiratory infections, gastrointestinal infections)

• Healthcare (prescribed for a wide range of bacterial infections)

• Research (studies on antibiotic resistance, bacterial DNA replication, and fluoroquinolone therapies)

• Manufacturing (production of oral tablets, injectables, and topical antibiotic formulations)

🧪 Available Grades:

• Pharmaceutical Grade (IP/BP/USP)

• Reagent Grade

• Laboratory Grade

⚙️ Functions:

• Broad-spectrum antibiotic used to treat various bacterial infections

• Inhibits DNA gyrase, preventing bacterial replication and growth

• Used to treat respiratory, urinary, gastrointestinal, and skin infections

• Reagent for antibiotic resistance research and bacterial DNA studies

• Effective against a wide range of Gram-negative and Gram-positive bacteria

🧩 Classified Under:

• Pharmaceuticals

• Antibiotics

• Fluoroquinolones

• Active Pharmaceutical Ingredients (APIs)

• Infection Treatment Medications